#Throwback to our Nasopharyngeal Carcinoma (NPC) symposium in July
Group photo from the NPC conference (L-R): Dr Eugenia Yeo Li Ling, Ms Jialing Neo, Prof Maria Lung, Prof Jens Samol, Prof Sue S. Yom, Prof Darren Lim, Prof Liu Jianjun, A/Prof Melvin Chua Lee Kiang, Prof Thomas Loh Kwok Seng, Prof. Jaap Middeldorp, Assistant Professor Joshua Tay, A/Prof Ian Cheong, Dr Tan Lu Ping
Jointly organised by the three local teams involved in the National Medical Research Council Open Fund – Large collaborative Grant (NMRC OF-LCG) program – A*STAR Genome Institute of Singapore (A*STAR’s GIS), National Cancer Centre Singapore (NCCS) and National University of Singapore (NUS), the symposium was a concerted effort to update and network with the scientific and healthcare community about the ongoing collaborative research efforts on advancing early diagnosis and personalised treatments of NPC through EBV-based strategies. The event was graced by Prof Lim Soon Thye, CEO & Senior Consultant, Division of Medical Oncology at NCCS.
With three main themes centred on NPC treatment and management, population screening and early diagnosis, and NPC genetics, the symposium was filled with lively discussions and questions fielded by the audience. The highlight of the symposium was the presentations by the three distinguished international keynote speakers – Prof Sue S. Yom, Prof. Jaap Middeldorp and Prof Maria Lung, who were also the scientific advisory panel for the NMRC OF-LCG program.
While the conference may have concluded in July, the research work continues. The NUS team is currently recruiting healthy volunteers for the community screening research programme, while the NCCS team has commenced their combination chemotherapy-immunotherapy clinical trial (RIBBON-LA-01) for high-risk locally-advanced NPC.
